Catalyst Wire Dossier Catalyst Wire Dossier

BIIB 722 CL Tablets

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIIB 722 CL Tablets, covering 2014-10-20 to 2014-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers [Phase 1]

See pricing